Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00229086 · ClinicalTrials.gov registry record

Gatekeeper European 005

A clinical trial, sponsored by MedtronicNeuro.

Terminated
Registry status
55
Enrollment target

NCT00229086 is a clinical trial that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00229086 was terminated before completion, sponsored by MedtronicNeuro.

TERMINATED
Registry status
55 participants
Enrollment target

Study Summary

Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04

Interventions

  • DEVICE Gatekeeper Reflux Repari System (Device)

Trial Details

FieldValue
Enrollment Target 55 participants

Sponsor

MedtronicNeuro

51 total trials

What the Registry Record Tells You About NCT00229086

The ClinicalTrials.gov registry entry for NCT00229086 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Gatekeeper Reflux Repari System (Device) is the first listed.

NCT00229086 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00229086 about?

NCT00229086 is a clinical study titled "Gatekeeper European 005". Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04

What is the current status of trial NCT00229086?

This trial is currently terminated. The enrollment target is 55 participants.

What interventions are being tested in trial NCT00229086?

The interventions under investigation include: Gatekeeper Reflux Repari System (Device) (DEVICE).

Who is sponsoring clinical trial NCT00229086?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.